Although in contrast to K14MycER mice, p53 is often mutated in sebaceous carcinoma (Kiyosaki et al., 2010) as a result of DNA damage, and these mutations are still capable of inhibiting AR activity when tested in prostate cells (Nesslinger et al., 2003). This evidence concerns the gene TP53 and sebaceous adenocarcinoma.